Hospital

Citius Pharmaceuticals: Citius to launch $2.5B in pre-clinical trial on a new drug for Parkinson’s disease

The Citius pharmaceutical company is set to announce a $2 billion pre-market study of its new drug, Axiomel.

The company’s chairman and chief executive officer, James L. Zymanski, will make the announcement at a news conference in Washington Thursday, according to a release from the company.

Axiomelo is a combination of a previously developed compound from its cancer-fighting Axiomil brand, which was developed in collaboration with pharmaceuticals company Cervarix.

Zymanski said Axiomela will be approved by the Food and Drug Administration and begin to be tested in patients around the country in a few weeks.

“We will take a clinical trial to ensure Axiomeli is approved by our regulatory agencies,” Zymansky said in the release.

“We have already seen tremendous results with Axiomels pre-approval by the FDA, so we are confident in the product.”

The company plans to begin clinical trials on Axiomeline, which is a proprietary combination of the drug’s main ingredient, Axoixol.

It will initially begin with a small trial, Zymanksi said.

“A small clinical trial of Axiomelec is a good first step to ensure that AxiomELIs approval is safe and well-received,” he said.

The announcement comes at a time when the nation’s largest pharmaceutical companies are struggling to overcome a shortage of the rare and powerful drug, which has driven up drug prices and raised questions about the efficacy of its FDA-approved treatment.

“The FDA and other regulatory agencies are continuing to examine the safety and efficacy of Axomel, and we look forward to further discussion with FDA regarding the clinical trial,” Zysamanski said.

“This will allow us to accelerate our pre-release program to obtain sufficient clinical data to support our premarket approval.”

Cervarax, the first FDA-approved drug to treat Parkinson’s, has been on the market for almost five years.

In 2016, the drug was approved for the treatment of multiple sclerosis.

Citius PharmaceuticalS, the third-largest pharmaceutical company in the United States, is the biggest US drugmaker, with a market value of $4.4 billion, according, according TOJO.

The company’s shares have climbed nearly 17 percent in 2017, and its stock has risen about 30 percent in the past year.

SPONSORSHIP BENEFITS

우리카지노 | Top 온라인 카지노사이트 추천 - 더킹오브딜러.바카라사이트쿠폰 정보안내 메리트카지노(더킹카지노),샌즈카지노,솔레어카지노,파라오카지노,퍼스트카지노,코인카지노.Best Online Casino » Play Online Blackjack, Free Slots, Roulette : Boe Casino.You can play the favorite 21 Casino,1xBet,7Bit Casino and Trada Casino for online casino game here, win real money! When you start playing with boecasino today, online casino games get trading and offers. Visit our website for more information and how to get different cash awards through our online casino platform.2021 베스트 바카라사이트 | 우리카지노계열 - 쿠쿠카지노.2021 년 국내 최고 온라인 카지노사이트.100% 검증된 카지노사이트들만 추천하여 드립니다.온라인카지노,메리트카지노(더킹카지노),파라오카지노,퍼스트카지노,코인카지노,바카라,포커,블랙잭,슬롯머신 등 설명서.【우리카지노】바카라사이트 100% 검증 카지노사이트 - 승리카지노.【우리카지노】카지노사이트 추천 순위 사이트만 야심차게 모아 놓았습니다. 2021년 가장 인기있는 카지노사이트, 바카라 사이트, 룰렛, 슬롯, 블랙잭 등을 세심하게 검토하여 100% 검증된 안전한 온라인 카지노 사이트를 추천 해드리고 있습니다.한국 NO.1 온라인카지노 사이트 추천 - 최고카지노.바카라사이트,카지노사이트,우리카지노,메리트카지노,샌즈카지노,솔레어카지노,파라오카지노,예스카지노,코인카지노,007카지노,퍼스트카지노,더나인카지노,바마카지노,포유카지노 및 에비앙카지노은 최고카지노 에서 권장합니다.